Table 4. Kp342 Antibiotic Resistance Profile.
| Drug Family | Drug (μg) | Phenotype | Diameter Zone of Inhibition (mm) | |||
| Interpretive Standards | ||||||
| Observed | Resistance | Intermediate | Sensitive | |||
| Aminocoumarin | Novobiocin (30) | Resistant | 0 | ≤17 | ||
| Aminoglycoside | Gentamicin (10) | Intermediate | 14 | 13–14 | ||
| Kanamycin (30) | Sensitive | 30 | ≥18 | |||
| Neomycin (30) | Resistant | 9 | ≤12 | |||
| B-Lactam | ||||||
| Cephalosporin | Cefotaxime (30) | Sensitive | 25 | ≥23 | ||
| Cefoperazone (75) | Sensitive | 24 | ≥21 | |||
| Cefazolin (30) | Sensitive | 20 | ≥18 | |||
| Ceftriaxone (30) | Intermediate | 15 | 14–20 | |||
| Cefuroxime (30) | Intermediate | 15 | 15–17 | |||
| Cephalothin (30) | Resistant | 14 | ≤14 | |||
| Moxalactam (30) | Intermediate | 22 | 15–22 | |||
| B-Lactam | ||||||
| Penicillin | Ampicillin (10) | Resistant | 0 | ≤15 | ||
| Mezlocillin (75) | Intermediate | 18 | 18–20 | |||
| Penicillin (10) | Resistant | 0 | ||||
| Piperacillin (100) | Intermediate | 19 | 18–20 | |||
| Ticarcillin (75) | Resistant | 7 | ≤14 | |||
| Macrolide | Azithromycin (15) | 10 | * | |||
| Erythromycin (15) | Resistant | 0 | * | |||
| Quinolone | Ciproflaxacin (5) | Intermediate | 18 | 16–20 | ||
| Nalidixic acid (30) | Resistant | 8 | ≤13 | |||
| Norfloxacin (10) | Resistant | 0 | ≤12 | |||
| Oxolinic acid (2) | Resistant | 7 | ≤10 | |||
| Sulfonamide | Sulfisoxazole (0.25) | Resistant | 8 | ≤12 | ||
| Trimethoprim (5) | Resistant | 0 | ≤10 | |||
| Tetracycline | Minocycline (30) | Resistant | 8 | ≤14 | ||
| Oxytetracycline (30) | Resistant | 0 | * | |||
| Tetracycline (30) | Resistant | 10 | ≤14 | |||
| Other | Rifampin (5) | Resistant | 0 | * | ||
*: No interpretive standards given for the Enterobacteriacaeae.